Nu Skin Enterprises (NUS) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nu Skin Enterprises, Inc. is set to experience a leadership shift as Joseph Chang steps down as Chief Scientific Officer on March 30, 2024, moving on to lead the company’s Scientific Advisory Board. This change comes as the Board of Directors decides that the Chief Scientific Officer will no longer be part of the executive team. The company acknowledges Dr. Chang’s significant contributions over his 20-year tenure and anticipates his ongoing guidance in his new role.
For further insights into NUS stock, check out TipRanks’ Stock Analysis page.